Bridge Biotherapeutics, Inc.
Hyung Eun Kim is the Director and Head of Pharmacovigilance at Bridge Biotherapeutics, Inc. Previously, Kim held various positions at GSK, including Head of Medical Operations/Pharmacovigilance and Head of Medical Information/Medical Operations. Kim also worked as a Drug Safety Officer at the Korea Institute of Drug Safety & Risk Management and as a Registered Pharmacist at Walgreens. With a Bachelor's degree in Pharmacy from Ewha Womans University and a Master's degree in Pharmacy from Seoul National University, Kim has a strong educational background to support their extensive experience in the pharmaceutical industry.
This person is not in any teams
This person is not in any offices
Bridge Biotherapeutics, Inc.
Bridge Biotherapeutics, Inc. is a virtually-operated, venture-backed clinical stage global biotech company, headquartered in Seongnam, Korea with its subsidiary at JLABS@TMC, engaged in the development of novel therapeutics, focusing on therapeutic areas of high unmet medical needs, such as ulcerative colitis, fibrotic diseases, and cancers.